ACVR1 and RRAS2 |
activin A receptor, type I |
related RAS viral (r-ras) oncogene homolog 2 |
|
|
- Adenosine triphosphate
- 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine
|
|
|
|
APOE and ALB |
apolipoprotein E |
albumin |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- Lipoprotein metabolism
- Bile acid and bile salt metabolism
- Metabolism of lipids and lipoproteins
- Recycling of bile acids and salts
- Platelet degranulation
- Lipid digestion, mobilization, and transport
- Transport of organic anions
- SLC-mediated transmembrane transport
- HDL-mediated lipid transport
- Scavenging of heme from plasma
- Response to elevated platelet cytosolic Ca2+
- Platelet activation, signaling and aggregation
- Transport of vitamins, nucleosides, and related molecules
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
PIK3R1 and ANK3 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
ankyrin 3, node of Ranvier (ankyrin G) |
- Signaling by the B Cell Receptor (BCR)
- Signaling by GPCR
- Metabolism of lipids and lipoproteins
- Signaling by FGFR in disease
- Signaling by EGFRvIII in Cancer
- Signaling by SCF-KIT
- Downstream signaling events of B Cell Receptor (BCR)
- DAP12 signaling
- PI3K/AKT activation
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Interleukin receptor SHC signaling
- PI-3K cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- Signaling by FGFR1 mutants
- Interleukin-7 signaling
- Role of phospholipids in phagocytosis
- Phospholipid metabolism
- Fcgamma receptor (FCGR) dependent phagocytosis
- PI3K Cascade
- Signaling by PDGF
- DAP12 interactions
- GAB1 signalosome
- G-protein beta:gamma signalling
- CD28 co-stimulation
- CD28 dependent PI3K/Akt signaling
- Signaling by ERBB4
- Constitutive PI3K/AKT Signaling in Cancer
- Role of LAT2/NTAL/LAB on calcium mobilization
- PI3K events in ERBB4 signaling
- G alpha (q) signalling events
- Signaling by ERBB2
- Signaling by EGFR
- GPCR downstream signaling
- Signaling by Interleukins
- TCR signaling
- Signaling by VEGF
- GP1b-IX-V activation signalling
- Downstream signal transduction
- Signaling by FGFR mutants
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- Nephrin interactions
- Interleukin-2 signaling
- PI3K/AKT Signaling in Cancer
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
- Adaptive Immune System
- G alpha (q) signalling events
- Downstream TCR signaling
- Costimulation by the CD28 family
- IRS-mediated signalling
- PIP3 activates AKT signaling
- IGF1R signaling cascade
- VEGFA-VEGFR2 Pathway
- Synthesis of PIPs at the plasma membrane
- IRS-related events triggered by IGF1R
- G beta:gamma signalling through PI3Kgamma
- PI3K events in ERBB2 signaling
- Regulation of signaling by CBL
- Downstream signaling of activated FGFR
- G alpha (12/13) signalling events
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- PI Metabolism
- Innate Immune System
- Signaling by Insulin receptor
- Signalling by NGF
- Insulin receptor signalling cascade
- Cytokine Signaling in Immune system
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- IRS-related events
- NGF signalling via TRKA from the plasma membrane
- Tie2 Signaling
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Cell surface interactions at the vascular wall
- Signaling by FGFR
- IRS-mediated signalling
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- GPVI-mediated activation cascade
- Interleukin receptor SHC signaling
- Signaling by FGFR1 fusion mutants
- Constitutive Signaling by EGFRvIII
- PI3K Cascade
|
- Interaction between L1 and Ankyrins
- Axon guidance
- L1CAM interactions
|
- Isoproterenol
- (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
|
|
|
|
APOE and TYRO3 |
apolipoprotein E |
TYRO3 protein tyrosine kinase |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and RNF32 |
apolipoprotein E |
ring finger protein 32 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and CDC37 |
apolipoprotein E |
cell division cycle 37 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- Signaling by ERBB2
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Signaling by EGFR in Cancer
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- Signaling by EGFRvIII in Cancer
- Constitutive Signaling by EGFRvIII
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and NEFM |
apolipoprotein E |
neurofilament, medium polypeptide |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and RPL4 |
apolipoprotein E |
ribosomal protein L4 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- Nonsense-Mediated Decay (NMD)
- Translation
- SRP-dependent cotranslational protein targeting to membrane
- Eukaryotic Translation Termination
- Peptide chain elongation
- Influenza Infection
- Viral mRNA Translation
- L13a-mediated translational silencing of Ceruloplasmin expression
- Influenza Life Cycle
- Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
- Influenza Viral RNA Transcription and Replication
- GTP hydrolysis and joining of the 60S ribosomal subunit
- Eukaryotic Translation Initiation
- Formation of a pool of free 40S subunits
- Eukaryotic Translation Elongation
- Cap-dependent Translation Initiation
- Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and PRAM1 |
apolipoprotein E |
PML-RARA regulated adaptor molecule 1 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and VLDLR |
apolipoprotein E |
very low density lipoprotein receptor |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and IQSEC1 |
apolipoprotein E |
IQ motif and Sec7 domain 1 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and CYP2C8 |
apolipoprotein E |
cytochrome P450, family 2, subfamily C, polypeptide 8 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
- Metabolism of lipids and lipoproteins
- Metabolic disorders of biological oxidation enzymes
- Phase 1 - Functionalization of compounds
- Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
- Arachidonic acid metabolism
- Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
- Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
- Cytochrome P450 - arranged by substrate type
- CYP2E1 reactions
- Biological oxidations
- Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
- Defective FMO3 causes Trimethylaminuria (TMAU)
- Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
- Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)
- Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
- Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
- Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
- Defective CYP1B1 causes Glaucoma
- Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
- Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
- Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
- Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
- Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
- Xenobiotics
- Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
- Defective MAOA causes Brunner syndrome (BRUNS)
- Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
- Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and CYP2C18 |
apolipoprotein E |
cytochrome P450, family 2, subfamily C, polypeptide 18 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
- Defective FMO3 causes Trimethylaminuria (TMAU)
- Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
- Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
- Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
- Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
- Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
- Metabolic disorders of biological oxidation enzymes
- Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
- Phase 1 - Functionalization of compounds
- Defective CYP1B1 causes Glaucoma
- Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
- Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
- Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
- Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
- Xenobiotics
- Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
- Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
- Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
- Cytochrome P450 - arranged by substrate type
- Defective MAOA causes Brunner syndrome (BRUNS)
- Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
- Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
- Biological oxidations
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and MID1IP1 |
apolipoprotein E |
MID1 interacting protein 1 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and PSEN1 |
apolipoprotein E |
presenilin 1 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- Degradation of the extracellular matrix
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and MAPT |
apolipoprotein E |
microtubule-associated protein tau |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- Apoptotic cleavage of cellular proteins
- Programmed Cell Death
- Apoptotic execution phase
- Caspase-mediated cleavage of cytoskeletal proteins
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and FOXG1 |
apolipoprotein E |
forkhead box G1 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and ARFGAP1 |
apolipoprotein E |
ADP-ribosylation factor GTPase activating protein 1 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- IRE1alpha activates chaperones
- COPI Mediated Transport
- XBP1(S) activates chaperone genes
- Golgi to ER Retrograde Transport
- Unfolded Protein Response (UPR)
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and APP |
apolipoprotein E |
amyloid beta (A4) precursor protein |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- Signaling by GPCR
- Platelet degranulation
- Metabolic disorders of biological oxidation enzymes
- RIP-mediated NFkB activation via ZBP1
- Formyl peptide receptors bind formyl peptides and many other ligands
- Amyloids
- Toll Like Receptor TLR1:TLR2 Cascade
- Peptide ligand-binding receptors
- Toll Like Receptor 5 (TLR5) Cascade
- The NLRP3 inflammasome
- Gastrin-CREB signalling pathway via PKC and MAPK
- Response to elevated platelet cytosolic Ca2+
- MyD88 dependent cascade initiated on endosome
- Toll Like Receptor 9 (TLR9) Cascade
- G alpha (i) signalling events
- TRIF-mediated TLR3/TLR4 signaling
- Toll Like Receptor 2 (TLR2) Cascade
- G alpha (q) signalling events
- GPCR downstream signaling
- Toll Like Receptor 4 (TLR4) Cascade
- Toll Like Receptor 3 (TLR3) Cascade
- Platelet activation, signaling and aggregation
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- G alpha (q) signalling events
- Class A/1 (Rhodopsin-like receptors)
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- Toll Like Receptor TLR6:TLR2 Cascade
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- Activated TLR4 signalling
- MyD88 cascade initiated on plasma membrane
- ZBP1(DAI) mediated induction of type I IFNs
- ECM proteoglycans
- MyD88:Mal cascade initiated on plasma membrane
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- Advanced glycosylation endproduct receptor signaling
- Innate Immune System
- Inflammasomes
- Cytosolic sensors of pathogen-associated DNA
- MyD88-independent cascade
- GPCR ligand binding
- Toll-Like Receptors Cascades
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Toll Like Receptor 10 (TLR10) Cascade
- Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
- TRAF6 mediated NF-kB activation
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|
APOE and ZNF558 |
apolipoprotein E |
zinc finger protein 558 |
- Lipoprotein metabolism
- Metabolism of lipids and lipoproteins
- Chylomicron-mediated lipid transport
- Lipid digestion, mobilization, and transport
- Diseases associated with visual transduction
- HDL-mediated lipid transport
- Visual phototransduction
- Scavenging by Class A Receptors
- Retinoid metabolism and transport
|
- Generic Transcription Pathway
|
- Human Serum Albumin
- Serum albumin iodonated
|
|
|
|